Skip to main content
# Title Department Research Year
2631 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
Department of Medicinal Chemistry 2005
2632 The biological effects of selenocysteine prodrugs. Department of Medicinal Chemistry 2005
2633 Chemometrics assisted spectrophotometric method for simultaneous determination of certain fluoroquinolones and their decarboxylated degradants
Department of Pharmaceutical Analytical Chemistry 2005
2634 Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study. Department of Pharmaceutics 2005
2635 Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. Department of Pharmaceutics 2005
2636 Synthesis of Some New 1,4-Disubstituted Piperazine-2,3-dione Derivatives of Potential Anthelmintic Activity Department of Pharmaceutical Organic Chemistry 2005
2637 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
Department of Medicinal Chemistry 2005
2638 Uptake of L-Selenaproline by the L-Cystine Transport System in Escherichia coli. Department of Medicinal Chemistry 2005
2639 Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice. Department of Pharmaceutics 2005
2640 Enhanced delivery of c-secretase inhibitor DAPT into the brain via an ascorbic acid mediated strategy Department of Medicinal Chemistry 2005